I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Combination therapy of tyrosine kinase inhibitor sorafenib ..:
Lundgren Mortensen, Anja Charlotte
;
Berglund, Hanna
;
Hariri, Mehran
...
Scientific Reports, 2023, 13:1,. , 2023
Link:
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-515076
RT Journal T1
Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftuppsalauniv:oai:DiVA.org:uu-515076&Exemplar=1&LAN=DE A1 Lundgren Mortensen, Anja Charlotte A1 Berglund, Hanna A1 Hariri, Mehran A1 Papalanis, Eleftherios A1 Malmberg, Christer A1 Spiegelberg, Diana PB Uppsala universitet, Cancerprecisionsmedicin; Uppsala universitet, Institutionen för immunologi, genetik och patologi; Uppsala universitet, Infektionsmedicin; Uppsala universitet, Öron-, näs- och halssjukdomar; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden YR 2023 K1 Endocrinology and Diabetes K1 Endokrinologi och diabetes K1 Cancer and Oncology K1 Cancer och onkologi JF Scientific Reports, 2023, 13:1, LK http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-515076 DO http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-515076 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)